Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Brivudine

An antiviral thymidine analogue first synthesised in 1976 at the University of Birmingham: in 1979 Erik De Clercq, at the Rega Institute in Belgium, discovered its strong activity against herpes simplex type 1 and varicella-zoster virus. It is used for herpes zoster (shingles). This family brings together the active ingredient and other impurities.

Did you know?Its name sums up its chemical structure, bromovinyl-deoxyuridine (BVDU). It reached pharmacies in the 1980s in East Germany, and only later in the rest of Europe.

BrivudineGo to the active ingredient →
BrivudineActive ingredientBrivudineCat. No. P-B112-001CAS 69304-47-8
L-BvduImpurityL-BvduCat. No. P-B112-037CAS 166735-83-7

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.